Johnson & Johnson Total Long Term Liabilities 2010-2024 | JNJ

Johnson & Johnson total long term liabilities for the quarter ending September 30, 2024 were $56.370B, a 11.71% increase year-over-year.

  • Johnson & Johnson total long term liabilities for 2023 were $52.502B, a 4.14% decline from 2022.
  • Johnson & Johnson total long term liabilities for 2022 were $54.772B, a 12.74% decline from 2021.
  • Johnson & Johnson total long term liabilities for 2021 were $62.769B, a 9.19% decline from 2020.

Johnson & Johnson Total Long Term Liabilities 2010-2024 | JNJ

  • Johnson & Johnson total long term liabilities for 2023 were $52.502B, a 4.14% decline from 2022.
  • Johnson & Johnson total long term liabilities for 2022 were $54.772B, a 12.74% decline from 2021.
  • Johnson & Johnson total long term liabilities for 2021 were $62.769B, a 9.19% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$789.4B
Novo Nordisk (NVO)$481.1B
AbbVie (ABBV)$352.5B
Merck (MRK)$260.4B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Pfizer (PFE)$151.4B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B